Changes of protein expression profiles in the amygdala during the process of morphine-induced conditioned place preference in rats

Behavioural Brain Research

Volumn 221, Issue 1, 2011, Pages 197-206

  Lin, XiaoJing ^a   Wang, QingSong ^a   Cheng, Yong ^a   Ji, Jianguo ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Addiction; Amygdala; Conditioned place preference; Proteomics

Indexed keywords

ALPHA GLUCOSIDASE; DYNAMIN; FORMATE TETRAHYDROFOLATE LIGASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMINASE; GLUTATHIONE TRANSFERASE; GLYCOGEN PHOSPHORYLASE; HEXOKINASE 1; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MORPHINE; OXOGLUTARATE DEHYDROGENASE; PALMITOYL COENZYME A HYDROLASE; PEROXIREDOXIN 4; PHOSPHOGLYCERATE MUTASE; PROTEASOME; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SEPTIN; SODIUM CHLORIDE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; SYNAPSIN; TRIOSEPHOSPHATE ISOMERASE; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUITIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CELL METABOLISM; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; REINFORCEMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AMYGDALA; ANIMALS; CHOICE BEHAVIOR; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MORPHINE; MORPHINE DEPENDENCE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 79953118182     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.002     Document Type: Article

References (62)

1. Chao J., Nestler E.J. Molecular neurobiology of drug addiction. Annu Rev Med 2004, 55:113-132.
2. Hooker C.I., Germine L.T., Knight R.T., D'Esposito M. Amygdala response to facial expressions reflects emotional learning. J Neurosci 2006, 26:8915-8922.
3. Robbins T.W., Ersche K.D., Everitt B.J. Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 2008, 1141:1-21.
4. Carelli R.M., Williams J.G., Hollander J.A. Basolateral amygdala neurons encode cocaine self-administration and cocaine-associated cues. J Neurosci 2003, 23:8204-8211.
5. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
6. Fuchs R.A., Bell G.H., Ramirez D.R., Eaddy J.L., Su Z.I. Basolateral amygdala involvement in memory reconsolidation processes that facilitate drug context-induced cocaine seeking. Eur J Neurosci 2009, 30:889-900.
7. Buffalari D.M., See R.E. Amygdala mechanisms of Pavlovian psychostimulant conditioning and relapse. Curr Top Behav Neurosci 2010, 3:73-99.
8. Koob G.F. Brain stress systems in the amygdala and addiction. Brain Res 2009, 1293:61-75.
9. See R.E., McLaughlin J., Fuchs R.A. Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience 2003, 117:477-483.
10. Hayes R.J., Vorel S.R., Spector J., Liu X., Gardner E.L. Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat. Psychopharmacology (Berl) 2003, 168:75-83.
11. See R.E., Fuchs R.A., Ledford C.C., McLaughlin J. Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci 2003, 985:294-307.
12. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998, 56:613-672.
13. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
14. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 2000, 153:31-43.
15. Nestler E.J. Psychogenomics: opportunities for understanding addiction. J Neurosci 2001, 21:8324-8327.
16. Abul-Husn N.S., Devi L.A. Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther 2006, 318:461-468.
17. Li C.Y., Mao X., Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008, 4:e2.
18. Williams K., Wu T., Colangelo C., Nairn A.C. Recent advances in neuroproteomics and potential application to studies of drug addiction. Neuropharmacology 2004, 47(Suppl. 1):148-166.
19. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., Schoffelmeer A.N., Smit A.B. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008.
20. Prokai L., Zharikova A.D., Stevens S.M. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J Mass Spectrom 2005, 40:169-175.
21. Bierczynska-Krzysik A., Pradeep John J.P., Silberring J., Kotlinska J., Dylag T., Cabatic M., et al. Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med 2006, 18:775-784.
22. Lin X., Wang Q., Ji J., Yu L.C. Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area. J Neurosci Res 2010, 88:1595-1604.
23. Shui H.A., Ho S.T., Wang J.J., Wu C.C., Lin C.H., Tao Y.X., et al. Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection. Proteomics 2007, 7:796-803.
24. Kim S.Y., Chudapongse N., Lee S.M., Levin M.C., Oh J.T., Park H.J., et al. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 2005, 133:58-70.
25. Moron J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics 2007, 6:29-42.
26. Yang L., Sun Z.S., Zhu Y.P. Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 2007, 6:2239-2247.
27. Xiong W., Gao L., Sapra A., Yu L.C. Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systems. Regul Pept 2005, 132:85-90.
28. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
29. Mu P., Yu L.C. Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. Neurosci Lett 2007, 426:135-138.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, Sydney.
31. Liu Y., He J., Ji S., Wang Q., Pu H., Jiang T., et al. Comparative studies of early liver dysfunction in senescence-accelerated mouse using mitochondrial proteomics approaches. Mol Cell Proteomics 2008, 7:1737-1747.
32. Yang W., Liu P., Liu Y., Wang Q., Tong Y., Ji J. Proteomic analysis of rat pheochromocytoma PC12 cells. Proteomics 2006, 6:2982-2990.
33. Gobom J., Schuerenberg M., Mueller M., Theiss D., Lehrach H., Nordhoff E. Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Anal Chem 2001, 73:434-438.
34. Shen Y., Yu L.C. Potential protection of curcumin against hypoxia-induced decreases in beta-III tubulin content in rat prefrontal cortical neurons. Neurochem Res 2008, 33:2112-2117.
35. Li J.J., Zhou X., Yu L.C. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation. Pain 2005, 118:232-242.
36. Hwang Y.Y., Li M.D. Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/MS-based proteomics approach. Proteomics 2006, 6:3138-3153.
37. Xie Y., Vessey J.P., Konecna A., Dahm R., Macchi P., Kiebler M.A. The GTP-binding protein Septin 7 is critical for dendrite branching and dendritic-spine morphology. Curr Biol 2007, 17:1746-1751.
38. Tada T., Simonetta A., Batterton M., Kinoshita M., Edbauer D., Sheng M. Role of Septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Curr Biol 2007, 17:1752-1758.
39. Stiene-Martin A., Gurwell J.A., Hauser K.F. Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation. Brain Res Dev Brain Res 1991, 60:1-7.
40. Stiene-Martin A., Hauser K.F. Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum. Neurosci Lett 1993, 157:1-3.
41. Garrido E., Perez-Garcia C., Alguacil L.F., Diez-Fernandez C. The alpha2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration. Neurosci Lett 2005, 383:141-144.
42. Marie-Claire C., Courtin C., Roques B.P., Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 2004, 29:2208-2215.
43. Song P., Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39:281-286.
44. Mika J., Wawrzczak-Bargiela A., Osikowicz M., Makuch W., Przewlocka B. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav Immun 2009, 23:75-84.
45. Wen Z.H., Wu G.J., Hsu L.C., Chen W.F., Chen J.Y., Shui H.A., et al. N-Methyl-d-aspartate receptor antagonist MK-801 attenuates morphine tolerance and associated glial fibrillary acid protein up-regulation: a proteomic approach. Acta Anaesthesiol Scand 2008, 52:499-508.
46. Narita M., Suzuki M., Yajima Y., Suzuki R., Shioda S., Suzuki T. Neuronal protein kinase C gamma-dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine. Eur J Neurosci 2004, 19:479-484.
47. Nalepa G., Rolfe M., Harper J.W. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov 2006, 5:596-613.
48. Rambhia S., Mantione K.J., Stefano G.B., Cadet P Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med Sci Monit 2005, 11:BR386-BR396.
49. Bierczynska-Krzysik A., Bonar E., Drabik A., Noga M., Suder P., Dylag T., et al. Rat brain proteome in morphine dependence. Neurochem Int 2006, 49:401-406.
50. Mouledous L., Neasta J., Uttenweiler-Joseph S., Stella A., Matondo M., Corbani M., et al. Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization. Mol Pharmacol 2005, 68:467-476.
51. Yang L., Wang S., Lim G., Sung B., Zeng Q., Mao J. Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance. Pain 2008, 140:472-478.
52. Yang L., Wang S., Sung B., Lim G., Mao J. Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation. J Biol Chem 2008, 283:21703-21713.
53. Iwazaki T., McGregor I.S., Matsumoto I. Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res 2006, 1097:19-25.
54. Kane J.K., Konu O., Ma J.Z., Li M.D. Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Brain Res Mol Brain Res 2004, 132:181-191.
55. Ficklin M.B., Zhao S., Feng G. Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J Biol Chem 2005, 280:34088-34095.
56. Iacovelli L., Fulceri F., De Blasi A., Nicoletti F., Ruggieri S., Fornai F. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders. Exp Neurol 2006, 201:24-31.
57. Miller C.A., Marshall J.F. Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 2005, 47:873-884.
58. Valjent E., Corbille A.G., Bertran-Gonzalez J., Herve D., Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci USA 2006, 103:2932-2937.
59. Salzmann J., Marie-Claire C., Le Guen S., Roques B.P., Noble F. Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br J Pharmacol 2003, 40:831-838.
60. Sanna P.P., Simpson C., Lutjens R., Koob G. ERK regulation in chronic ethanol exposure and withdrawal. Brain Res 2002, 948:186-191.
61. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 2005, 8:212-219.
62. Li Y.Q., Li F.Q., Wang X.Y., Wu P., Zhao M., Xu C.M., et al. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 2008, 28:13248-13257.